West Penn Allegheny Health System's loss in 2013 balloons to $370M
Financial losses at West Penn Allegheny Health System ballooned to more than $370 million for its 2013 fiscal year, according to an audited financial report released on Thursday.
The loss was 2 1⁄2 times larger than the system originally reported in October, because the audited report included a non-cash charge of $214.7 million related to the value of assets and several other smaller changes, said Liz Allen, interim chief financial officer.
“It hasn't deteriorated the cash reserves of the organization,” Allen said of the impairment charge. “It's an accounting transaction.”
West Penn Allegheny reported a loss of $137.6 million for the year ended June 30 when it released unaudited financial statements six months ago.
The five-hospital system was acquired by health insurer Highmark Inc. on April 30, and it's the backbone of Allegheny Health Network, a system of doctors and hospitals formed by Highmark to compete against UPMC.
Allen said accounting rules required West Penn Allegheny to revalue its assets at the time of Highmark's acquisition.
The revaluation process revealed the system had a larger deficit between its assets and liabilities at the time of the deal, in which Highmark gave the system $475 million in grants and loans and bought West Penn Allegheny's bond debt for about $664 million.
West Penn Allegheny wrote off a portion of that deficit in assets, making the impairment charge of $214.7 million, Allen said.
While the reported loss last year looks worse on paper, Allen said, the system's financial turnaround is going well.
The system reported an operating loss of $2.1 million in the October-December quarter. In the same quarter the year before, the system had an operating loss of $33.1 million. Revenue rose to $406.4 million, compared with $385.8 million the year before.
“We've made some good progress, but we have more to go,” she said. “It's well ahead of our schedule.”
Alex Nixon is a staff writer for Trib Total Media.
Add Alex Nixon to your Google+ circles.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Wolf reverses Corbett, says deal between Highmark, UPMC doesn’t limit continuity of care to very ill
- Mud serves as multipurpose tool in $100B shale industry
- Researchers: U.S. lacks proving ground for nuclear energy innovations
- Big banks’ levels of capital strong, Federal Reserve finds
- AbbVie to buy leukemia drugmaker Pharmacyclics for $21 billion
- Americans see improved job market but a vulnerable economy, Pew poll finds
- IPO might test Etsy’s approach to commerce
- Race toward bigger phones eases
- Worker productivity falls faster than estimated; labor costs rise
- Stocks snap losing streak as ECB reveals stimulus start date
- Mylan closes $5.3B tax-lowering deal with Abbott Labs